Literature DB >> 26405386

Association of Low Serum Iron with Alpha Globin Gene Deletions and High Level of HbF with Xmn-1 Polymorphism in Sickle Cell Traits.

S Pandey1, R M Mishra2, A Suhail1, S Rahul1, K Ravi1, Sw Pandey1, T Seth1, R Saxena1.   

Abstract

Usually sickle cell traits are asymptomatic but co-existence of various factrors may alter the clinical as well as biochemical levels. In India sickle cell traits are neglected condition. Here we are presenting the alpha deletion in association with low serum iron and increased HbF level with Xmn-1 carriers in sickle cell traits. Sickle traits with alpha deletions had significantly low level of serum iron (P-value <0.05) with low level of reticulocytes and red cell indices while Xmn-1 polymorphism associated with increased HbF level. Study concludes low serum iron associated with alpha deletions and high level of HbF associated with Xmn-1 polymorphism in sickle cell traits.

Entities:  

Keywords:  Gap-PCR; Hemoglobinopathies; Sickle traits

Year:  2011        PMID: 26405386      PMCID: PMC4577506          DOI: 10.1007/s12291-011-0170-y

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  22 in total

1.  Single tube genotyping of sickle cell anaemia using PCR-based SNP analysis.

Authors:  C M Waterfall; B D Cobb
Journal:  Nucleic Acids Res       Date:  2001-12-01       Impact factor: 16.971

2.  Prevalence of -alpha(3.7) and alpha alpha alpha(anti3.7) alleles in sickle cell trait and beta-thalassemia patients in Mexico.

Authors:  María Paulina Nava; Bertha Ibarra; María Teresa Magaña; María de la Luz Chávez; F Javier Perea
Journal:  Blood Cells Mol Dis       Date:  2006-02-07       Impact factor: 3.039

Review 3.  Complications associated with sickle cell trait: a brief narrative review.

Authors:  Geoffrey Tsaras; Amma Owusu-Ansah; Freda Owusua Boateng; Yaw Amoateng-Adjepong
Journal:  Am J Med       Date:  2009-04-24       Impact factor: 4.965

4.  Rapid diagnosis of alpha-thalassemia-1 of southeast Asia type and hydrops fetalis by polymerase chain reaction.

Authors:  J G Chang; L S Lee; C P Lin; P H Chen; C P Chen
Journal:  Blood       Date:  1991-08-01       Impact factor: 22.113

5.  XmnI polymorphism is associated with fetal hemoglobin levels in hypoplastic syndromes.

Authors:  Marily Maria Azevedo Shimmoto; Perla Vicari; Andréa Cristina Fernandes; Gustavo Stuani Guimarães; Maria Stella Figueiredo
Journal:  Sao Paulo Med J       Date:  2006-03-02       Impact factor: 1.044

6.  Polymerase chain reaction amplification applied to the determination of beta-like globin gene cluster haplotypes.

Authors:  M Sutton; E E Bouhassira; R L Nagel
Journal:  Am J Hematol       Date:  1989-09       Impact factor: 10.047

7.  Detection of common deletional alpha-thalassemia-2 determinants by PCR.

Authors:  E Baysal; T H Huisman
Journal:  Am J Hematol       Date:  1994-07       Impact factor: 10.047

8.  Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia.

Authors:  S H Embury; A M Dozy; J Miller; J R Davis; K M Kleman; H Preisler; E Vichinsky; W N Lande; B H Lubin; Y W Kan; W C Mentzer
Journal:  N Engl J Med       Date:  1982-02-04       Impact factor: 91.245

9.  The interaction of alpha thalassaemia with heterozygous beta thalassaemia.

Authors:  E Kanavakis; J S Wainscoat; W G Wood; D J Weatherall; A Cao; M Furbetta; R Galanello; D Georgiou; T Sophocleous
Journal:  Br J Haematol       Date:  1982-11       Impact factor: 6.998

10.  Determination of the breakpoint and molecular diagnosis of a common alpha-thalassaemia-1 deletion in the Indian population.

Authors:  R V Shaji; S E Eunice; S Baidya; A Srivastava; M Chandy
Journal:  Br J Haematol       Date:  2003-12       Impact factor: 6.998

View more
  1 in total

1.  Association of Xmn1 -158 γG variant with severity and HbF levels in β-thalassemia major and sickle cell anaemia.

Authors:  Sneha Dadheech; Suman Jain; D Madhulatha; Vandana Sharma; James Joseph; A Jyothy; Anjana Munshi
Journal:  Mol Biol Rep       Date:  2014-02-02       Impact factor: 2.316

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.